| Thursday 7th March |
|
09.30 |
|
Arrival, Coffee & Registration
|
|
10.00 |
|
Introduction
Hugh Walton, Astex Therapeutics Ltd
|
|
10.10 |
|
Opening presentation
Rebecca Scott, GSK
|
|
10.30 |
|
First Talks on new in vitro techniques
Chair: Hugh Walton
- Jenny Rankin, Charles River
- Rosie Rawlinson, Sygnature Discovery
- Justine Badee, University of Florida/Roche
- Heather Edwardson, Evotec (UK) Ltd
|
|
11.40 |
|
Refreshments and Posters
|
|
12.00 |
|
Cell culture in DMPK
Chair: Rebecca Scott
- John Pollard, Charles River
- Mi-Young Lee, Unilever
- Katie Haughan, AstraZeneca
- Elnaz Gozalpour, AstraZeneca
|
|
13.00 |
|
Lunch
|
|
13.45 |
|
In vivo study design and LC/MS analysis
Chair: Hugh Walton
- Seshu Tammireddy, Envigo
- Mykel Evans, Sygnature Discovery Limited
- Coral Munday, LGC
- Caitlin Lapworth, GSK
- Alpesh Shah, Astex Therapeutics Ltd
|
|
15.00 |
|
Refreshments and Posters
|
|
15.15 |
|
Direct Measurement of Compound Binding
Chair: Rebecca Scott
- Vanessa Portman, Sygnature Discovery Limited
- Jenny Baker, LGC
- Claire Szuster, LGC
- Brett O’Brien, GSK
|
|
16.15 |
|
Poster prize and final viewings
|
|
16.50 |
|
Closing remarks
|
17.00 -
17.45 |
|
Break / Chill out
|
17.45 -
19.00 |
|
Meet up in 'The Eagle' |
| |
|
|